PQIAX
Price
$39.17
Change
+$0.45 (+1.16%)
Updated
Dec 20 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

PQIAX vs RMFCX

Header iconPQIAX vs RMFCX Comparison
Open Charts PQIAX vs RMFCXBanner chart's image
Principal Equity Income A
Price$39.17
Change+$0.45 (+1.16%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
PQIAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PQIAX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PQIAX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. PQIAX (8.74B). PQIAX (1.76) and RMFCX (1.69) have matching dividends . PQIAX was incepted earlier than RMFCX: PQIAX (86 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. PQIAX (13.30). RMFCX has a lower initial minimum investment than PQIAX: RMFCX (250) vs PQIAX (1000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. PQIAX (6.48). RMFCX return over 5 years is better than : 37.80 vs. PQIAX (22.51).
PQIAXRMFCXPQIAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence86 years23 years-
Gain YTD5.5219.92156%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.74B102B9%
Annual Yield % from dividends1.761.69104%
Returns for 1 year6.4811.1158%
Returns for 3 years0.6712.385%
Returns for 5 years22.5137.8060%
Returns for 10 years69.6659.36117%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA